The 20th edition of BioAsia – The Marquee Healthcare and Life Sciences event, organized by the Government of Telangana, has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof. Robert S. Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases. Langer is currently the David H. Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin, and vaccines.
Related Posts
6.1 Million Job Applications in Maharashtra Led by Freshers and Women: apna.co Report
Mumbai, 28th May 2024: Maharashtra’s job market has shown remarkable growth in the first four months of 2024, according to…
Ongo Tests Voice-Controlled Fueling with AI Assistant for Enhanced Experience
Bengaluru, 4th June 2024: AGS Transact Technologies Limited’s (BSE: 543451 & NSE: AGSTRA) digital payments platform, Ongo, today announced that…
SPJIMR & Emeritus Launch ‘AI for Business’ to Bridge Skills Gap
Mumbai, February 17, 2025: The world of business is rapidly transforming under the influence of artificial intelligence (AI). Organisations are…